Result of Subscription
For immediate release
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH FORMS PART OF THE LAWS OF ENGLAND AND WALES PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (UK MAR). UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE WITHIN THE PUBLIC DOMAIN.
EMV Capital plc
("EMV Capital" or the "Company" or the "Group")
Result of Subscription
Successful Subscription to raise £880,000
EMV Capital plc (AIM: EMVC), the deeptech and life sciences VC investment group, is pleased to announce, following its announcement made earlier today (Impact Announcement), the successful completion of the Subscription at the Issue Price of £0.50 per New Share for 1,760,000 New Shares, raising in aggregate £880,000 from new and existing shareholders. Terms defined in the Impact Announcement have the same meanings in this announcement.
Retail Offer
As announced earlier today, the Company also launched the Retail Offer through the Winterflood Retail Access platform to raise up to £620,000. The Retail Offer is expected to close at 4:30 p.m. on 4 December 2024, or such later time and date as the Company and Winterflood may agree, the results of which are expected to be announced on or around 5 December 2024.
Related party transactions
Director participation
Ilian Iliev (Chief Executive Officer) has participated in the Subscription by subscribing for 200,000 New Shares at the Issue Price, with payment therefor to be settled by releasing the Company from £100,000 of the annual bonus awarded to him for the year ended 31 December 2023, such amount being c.80 per cent. of such annual bonus.
Charles Spicer (Non-Executive Chair) and Ed Hooper (Executive Director) intend to participate in the Retail Offer by subscribing for New Shares (20,000 and 180,000 respectively) at the Issue Price via their respective Self-Invested Personal Pensions. Further details will be included in the announcement of the result of Retail Offer.
Ilian Iliev is deemed to be a related party pursuant to Rule 13 of the AIM Rules for Companies and his participation in the Fundraising (as described above) is a related party transaction for the purposes of such Rule (Director RPT).
The table below summarises the interests of Ilian Iliev in the Fundraising.
Existing beneficial shareholding | New Shares subscribed for | Shareholding on Admission | Shareholding as a percentage of the enlarged share capital upon Admission* |
3,661,457 | 200,000 | 3,861,457 | 14.11% |
*assuming the Retail Offer is fully subscribed
The information below the heading 'About EMV Capital plc (EMVC)', set out in accordance with the requirements of MAR, provides further detail.
Substantial Shareholder participation
A Beckman plc SSAS (Small Self Administered Pension Scheme), which is associated with Melvin Lawson, a substantial shareholder in the Company, has participated in the Subscription by subscribing for 100,000 New Shares at the Issue Price (Substantial Shareholder Participation). The Substantial Shareholder Participation is deemed to be a related party transaction pursuant to the AIM Rules for Companies (Shareholder RPT).
AIM Rule 13 fair and reasonable opinion
Jonathan Robinson, being the Director who is independent of the Director RPT and the Shareholder RPT (together Related Party Transactions), having consulted with the Company's nominated adviser, Panmure Liberum Limited, considers the terms of the Related Party Transactions to be fair and reasonable insofar as the Company's shareholders are concerned.
Admission
Application will be made to London Stock Exchange plc for the admission to trading on AIM of the Subscription Shares and such number of Retail Offer Shares as are subscribed for pursuant to the Retail Offer (Admission). It is expected that Admission will become effective and dealings will commence at 8.00 a.m. on or around 9 December 2024.
The person responsible for arranging the release of this announcement on behalf of the Company is Ed Hooper, Executive Director and General Counsel of the Company.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO 596/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.
-ends-
For more information, please contact:
| |
EMV Capital plc | via Rosewood |
Ilian Iliev, CEO | |
|
|
Panmure Liberum (UK) Limited (NOMAD and Broker) | +44 (0)20 7886 2500 |
Emma Earl / Will Goode / Freddy Crossley / Mark Rogers (Corporate Finance) | |
Rupert Dearden (Corporate Broking) | |
| |
Rosewood (Financial PR) | +44 (0)20 7653 8702 |
John West / Llewellyn Angus / Lily Pearce |
About EMV Capital plc (EMVC)
EMV Capital plc, formerly known as NetScientific plc, is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies.
With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future; EMV Capital invests in, manages and strengthens early stage IP-rich companies.
EMV Capital holds both direct equity stakes and carried interest in its portfolio companies, creating an evergreen structure that supports extensive growth and value creation. EMV Capital's investment thesis is realised through these capital sources:
· capital-efficient investments through Group balance sheet;
· fund management of the Evergreen EIS and Martlet Capital Funds;
· syndicated investments leveraging its network of third-party investors.
EMV Capital's approach is characterised by its proactive management style, aiming to advance portfolio companies to critical value inflection points by actively engaging with them. Companies are supported through Board representation and the use of its Value Creation Services practice.
Headquartered in London, with a Cambridge presence and strong international links, EMV Capital is quoted on the AIM market of the London Stock Exchange.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a) | Name | Dr Ilian Iliev | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director | ||||
b)
| Initial notification /Amendment | Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | EMV Capital plc | ||||
b) | LEI | 213800N5WD46G1Y7I458 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | EMVC 5p Ordinary Shares
GB00BN4R5Q82 | ||||
b) | Nature of the transaction | Subscription for new Ordinary Shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information - Aggregated volume
- Price
| N/a | ||||
e)
| Date of the transaction | 3 December 2024 | ||||
f)
| Place of the transaction | UK AIM |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.